Paul Tudor Jones Exelixis, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Exelixis, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 126,836 shares of EXEL stock, worth $4.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

126,836

Previous 145,611 12.89%

Holding current value

$4.3 Million

Previous $3.27 Million 0.61%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $412,299 - $518,190	-18,775 Reduced 12.89%	126,836 $3.29 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $2.96 Million - $3.46 Million	145,611 New	145,611 $3.27 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $594,228 - $744,868	-30,869 Reduced 18.15%	139,210 $3.34 Million
Q3 2023 Nov 15, 2023	SELL	$19.04 - $22.74 $102,301 - $122,182	-5,373 Reduced 3.06%	170,079 $3.72 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $3.19 Million - $3.59 Million	175,452 New	175,452 $3.35 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $888,005 - $1.26 Million	-56,633 Reduced 70.6%	23,584 $370,000
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $1.4 Million - $1.86 Million	80,217 New	80,217 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $469,195 - $608,514	-28,785 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $516,690 - $735,744	28,785 New	28,785 $524,000
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $1.7 Million - $2.22 Million	-82,451 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $1.36 Million - $2.26 Million	82,451 New	82,451 $1.96 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $1.53 Million - $1.91 Million	-101,253 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $1.09 Million - $1.4 Million	61,741 Added 156.26%	101,253 $1.79 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $747,962 - $977,922	39,512 New	39,512 $844,000
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $1.6 Million - $1.93 Million	-86,135 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $423,840 - $610,215	19,135 Added 28.56%	86,135 $1.91 Million
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $45,552 - $58,148	-1,880 Reduced 2.73%	67,000 $2.04 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $1.61 Million - $2.01 Million	68,880	68,880 $1.67 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account